Issue of Equity

Summary by AI BETAClose X

CQS New City High Yield Fund Limited announced the issuance of 3,000,000 ordinary shares at 50.6 pence per share, raising capital through its blocklisting facility. This transaction, expected to complete on May 29, 2026, will bring the company's total issued share capital to 683,401,858 ordinary shares with no shares held in treasury, resulting in a total of 683,401,858 voting rights. This figure will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

CQS New City High Yield Fund Ltd
27 May 2026
 

27 May 2026

 

 

CQS New City High Yield Fund Limited

(the Company)

 

Issue of Equity

 

On 27 May 2026, the Company agreed to issue 3,000,000 ordinary shares of no par value from its blocklisting facility at a price of 50.6 pence per share. The shares will be issued for cash on 29 May 2026.

 

On 29 May 2026, the Company's issued share capital will consist of 683,401,858 ordinary shares and there are no shares held in treasury. Therefore, the total number of voting rights in the Company will be 683,401,858 as of 29 May 2026.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

ENQUIRIES:         

 

Investment Manager

Manulife |CQS Investment Management

0207 201 5368

 

 

Craig Cleland

 

Company Secretary and Administrator

BNP Paribas S.A., Jersey Branch

01534 813 959

 

 

jersey.bp2s.cqs.operations@bnpparibas.com

 

Broker

Singer Capital Markets LLP

020 7496 3000

 

James Maxwell (Corporate Finance)

James Moat (Corporate Finance)

Alan Geeves (Sales)

Public Relations Adviser

Cardew Group

020 7930 0777

 

 

Tania Wild

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings